Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Tianli Pharmaceutical is a Chinese pharmaceutical company primarily engaged in the research, development, production, and sale of finished drug products and active pharmaceutical ingredients (APIs). The company operates a large-scale manufacturing facility in Shaanxi Province, focusing on a variety of therapeutic areas including anti-infectives, cardiovascular health, and gastrointestinal treatments. Their product portfolio includes tablets, capsules, and granules, often targeting the domestic Chinese market. Shaanxi Tianli is recognized for its adherence to Good Manufacturing Practice (GMP) standards and its role as a regional supplier of essential medicines. The company also engages in the production of traditional Chinese medicine (TCM) derivatives alongside modern chemical drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Tianli Pharmaceutical.